Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria

K. Gianmoena, N. Gasparoni, A. Jashari, P. Gabrys, K. Grgas, A. Ghallab, K. Nordstrom, G. Gasparoni, J. Reinders, K. Edlund, P. Godoy, A. Schriewer, H. Hayen, C.A. Hudert, G. Damm, D. Seehofer, T.S. Weiss, P. Boor, H.J. Anders, M. MotrapuP. Jansen, T.S. Schiergens, M. Falk-Paulsen, P. Rosenstiel, C. Lisowski, E. Salido, R. Marchan, J. Walter, J.G. Hengstler, C. Cadenas*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry